Our analysis indicates specific expression of SLC7A11 in MSCs, suggesting that MSCs or MSC-Exo may promote tumor cell disulfidptosis by enhancing SLC7A11 expression or function, potentially offering a novel direction for effective BC treatment. Here, SLC7A11 is linked to breast cancer.